Clostridium butyricum reduces the incidence of overt hepatic encephalopathy in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt (TIPS)
Clostridium butyricum reduces the incidence of overt hepatic encephalopathy in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt (TIPS). // Annals of Thoracic Surgery Short Reports. – URL: https://www.sciencedirect.com/science/article/pii/S1665268126000062?dgcid=rss_sd_all
Clostridium butyricum reduces the incidence of overt hepatic encephalopathy in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt (TIPS). Annals of Thoracic Surgery Short Reports. https://www.sciencedirect.com/science/article/pii/S1665268126000062?dgcid=rss_sd_all
“Clostridium butyricum reduces the incidence of overt hepatic encephalopathy in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt (TIPS).” Annals of Thoracic Surgery Short Reports.
@article{article3498,
title = {Clostridium butyricum reduces the incidence of overt hepatic encephalopathy in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt (TIPS)},
journal = {Annals of Thoracic Surgery Short Reports},
url = {https://www.sciencedirect.com/science/article/pii/S1665268126000062?dgcid=rss_sd_all}
}
Publication date: January–June 2027 Source: Annals of Hepatology, Volume 32, Issue 1 Author(s): Marie Louise N. Therkelsen, Liv Eline Hetland, Mikkel Parsberg Werge, Mira Thing, Elias Badal Rashu, Puria Nabilou, Nina Kimer, Anders...